{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:34:33Z","timestamp":1793637273925,"version":"4.5.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s40263-019-00688-2","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T15:02:38Z","timestamp":1575558158000},"page":"29-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment"],"prefix":"10.1007","volume":"34","author":[{"given":"Ni","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Huggon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-9927","authenticated-orcid":false,"given":"Kate E. A.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"3","key":"688_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241\u201351.","journal-title":"Arch Gen Psychiatry"},{"key":"688_CR2","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858."},{"key":"688_CR3","first-page":"3111","volume":"11","author":"B Bortolato","year":"2015","unstructured":"Bortolato B, Miskowiak KW, Kohler CA, Vieta E, Carvalho AF. Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat. 2015;11:3111\u201325.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"688_CR4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.euroneuro.2015.01.007","volume":"25","author":"A Martinez-Aran","year":"2015","unstructured":"Martinez-Aran A, Vieta E. Cognition as a target in schizophrenia, bipolar disorder and depression. Eur Neuropsychopharmacol. 2015;25(2):151\u20137.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"688_CR5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1037\/a0016277","volume":"23","author":"MM Kurtz","year":"2009","unstructured":"Kurtz MM, Gerraty RT. A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology. 2009;23(5):551\u201362.","journal-title":"Neuropsychology"},{"issue":"8","key":"688_CR6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1524-4733.2010.00768.x","volume":"13","author":"AR Rosa","year":"2010","unstructured":"Rosa AR, Reinares M, Michalak EE, Bonnin CM, Sole B, Franco C, et al. Functional impairment and disability across mood states in bipolar disorder. Value Health. 2010;13(8):984\u20138.","journal-title":"Value Health"},{"issue":"14","key":"688_CR7","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1017\/S0033291714000439","volume":"44","author":"KE Burdick","year":"2014","unstructured":"Burdick KE, Russo M, Frangou S, Mahon K, Braga RJ, Shanahan M, et al. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med. 2014;44(14):3083\u201396.","journal-title":"Psychol Med"},{"key":"688_CR8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jad.2016.08.018","volume":"205","author":"JH Jensen","year":"2016","unstructured":"Jensen JH, Knorr U, Vinberg M, Kessing LV, Miskowiak KW. Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: associations with functional abilities. J Affect Disord. 2016;205:378\u201386.","journal-title":"J Affect Disord"},{"issue":"3","key":"688_CR9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bdi.12385","volume":"18","author":"B Sole","year":"2016","unstructured":"Sole B, Jimenez E, Torrent C, Del Mar Bonnin C, Torres I, Reinares M, et al. Cognitive variability in bipolar II disorder: who is cognitively impaired and who is preserved. Bipolar Disord. 2016;18(3):288\u201399.","journal-title":"Bipolar Disord"},{"issue":"5","key":"688_CR10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/schbul\/sbu198","volume":"41","author":"E Bora","year":"2015","unstructured":"Bora E, Pantelis C. Meta-analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls. Schizophr Bull. 2015;41(5):1095\u2013104.","journal-title":"Schizophr Bull"},{"issue":"1","key":"688_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psychres.2014.12.044","volume":"226","author":"DJ Martino","year":"2015","unstructured":"Martino DJ, Samame C, Ibanez A, Strejilevich SA. Neurocognitive functioning in the premorbid stage and in the first episode of bipolar disorder: a systematic review. Psychiatry Res. 2015;226(1):23\u201330.","journal-title":"Psychiatry Res"},{"issue":"3","key":"688_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.psychres.2007.09.002","volume":"161","author":"E Bora","year":"2008","unstructured":"Bora E, Vahip S, Akdeniz F, Ilerisoy H, Aldemir E, Alkan M. Executive and verbal working memory dysfunction in first-degree relatives of patients with bipolar disorder. Psychiatry Res. 2008;161(3):318\u201324.","journal-title":"Psychiatry Res"},{"issue":"4","key":"688_CR13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S0033291715002147","volume":"46","author":"C McCormack","year":"2016","unstructured":"McCormack C, Green MJ, Rowland JE, Roberts G, Frankland A, Hadzi-Pavlovic D, et al. Neuropsychological and social cognitive function in young people at genetic risk of bipolar disorder. Psychol Med. 2016;46(4):745\u201358.","journal-title":"Psychol Med"},{"issue":"9","key":"688_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11920-015-0605-x","volume":"17","author":"T Cardoso","year":"2015","unstructured":"Cardoso T, Bauer IE, Meyer TD, Kapczinski F, Soares JC. neuroprogression and cognitive functioning in bipolar disorder: a systematic review. Curr Psychiatry Rep. 2015;17(9):75.","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"688_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1399-5618.2010.00835.x","volume":"12","author":"C Lopez-Jaramillo","year":"2010","unstructured":"Lopez-Jaramillo C, Lopera-Vasquez J, Gallo A, Ospina-Duque J, Bell V, Torrent C, et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord. 2010;12(5):557\u201367.","journal-title":"Bipolar Disord"},{"issue":"2","key":"688_CR16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1176\/appi.ajp.161.2.262","volume":"161","author":"A Martinez-Aran","year":"2004","unstructured":"Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262\u201370.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"688_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000083170","volume":"74","author":"V Balanza-Martinez","year":"2005","unstructured":"Balanza-Martinez V, Tabares-Seisdedos R, Selva-Vera G, Martinez-Aran A, Torrent C, Salazar-Fraile J, et al. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom. 2005;74(2):113\u20139.","journal-title":"Psychother Psychosom"},{"issue":"3","key":"688_CR18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.psychres.2013.01.003","volume":"210","author":"Y Braw","year":"2013","unstructured":"Braw Y, Erez G, Sela T, Gvirts HZ, Hare EV, Bloch Y, et al. A longitudinal study of cognition in asymptomatic and mildly symptomatic bipolar disorder patients. Psychiatry Res. 2013;210(3):842\u20139.","journal-title":"Psychiatry Res"},{"issue":"2","key":"688_CR19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/bdi.12374","volume":"18","author":"SN Schouws","year":"2016","unstructured":"Schouws SN, Comijs HC, Dols A, Beekman AT, Stek ML. Five-year follow-up of cognitive impairment in older adults with bipolar disorder. Bipolar Disord. 2016;18(2):148\u201354.","journal-title":"Bipolar Disord"},{"issue":"16","key":"688_CR20","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1017\/S0033291717001490","volume":"47","author":"E Bora","year":"2017","unstructured":"Bora E, Ozerdem A. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia. Psychol Med. 2017;47(16):2753\u201366.","journal-title":"Psychol Med"},{"key":"688_CR21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jad.2014.04.028","volume":"164","author":"C Samame","year":"2014","unstructured":"Samame C, Martino DJ, Strejilevich SA. Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. J Affect Disord. 2014;164:130\u20138.","journal-title":"J Affect Disord"},{"issue":"8","key":"688_CR22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S0033291718001885","volume":"49","author":"EM Sanchez-Morla","year":"2019","unstructured":"Sanchez-Morla EM, Lopez-Villarreal A, Jimenez-Lopez E, Aparicio AI, Martinez-Vizcaino V, Roberto RJ, et al. Impact of number of episodes on neurocognitive trajectory in bipolar disorder patients: a 5-year follow-up study. Psychol Med. 2019;49(8):1299\u2013307.","journal-title":"Psychol Med"},{"issue":"Suppl 2","key":"688_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/bdi.12341","volume":"17","author":"BT Baune","year":"2015","unstructured":"Baune BT, Malhi GS. A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder. Bipolar Disord. 2015;17(Suppl 2):41\u201355.","journal-title":"Bipolar Disord"},{"issue":"3","key":"688_CR24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/bdi.12148","volume":"16","author":"S Tse","year":"2014","unstructured":"Tse S, Chan S, Ng KL, Yatham LN. Meta-analysis of predictors of favorable employment outcomes among individuals with bipolar disorder. Bipolar Disord. 2014;16(3):217\u201329.","journal-title":"Bipolar Disord"},{"issue":"6","key":"688_CR25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","volume":"30","author":"GM Goodwin","year":"2016","unstructured":"Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495\u2013553.","journal-title":"J Psychopharmacol"},{"key":"688_CR26","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","volume":"346","author":"A Cipriani","year":"2013","unstructured":"Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646.","journal-title":"BMJ"},{"issue":"6","key":"688_CR27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jamapsychiatry.2016.0432","volume":"73","author":"JF Hayes","year":"2016","unstructured":"Hayes JF, Pitman A, Marston L, Walters K, Geddes JR, King M, et al. Self-harm, unintentional injury, and suicide in bipolar disorder during maintenance mood stabilizer treatment: a UK population-based electronic health records study. JAMA Psychiatry. 2016;73(6):630\u20137.","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"688_CR28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.4088\/JCP.08r04972","volume":"70","author":"AP Wingo","year":"2009","unstructured":"Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry. 2009;70(11):1588\u201397.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"688_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/YIC.0000000000000152","volume":"32","author":"A Paterson","year":"2017","unstructured":"Paterson A, Parker G. Lithium and cognition in those with bipolar disorder. Int Clin Psychopharmacol. 2017;32(2):57\u201362.","journal-title":"Int Clin Psychopharmacol"},{"key":"688_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eurpsy.2015.09.460","volume":"31","author":"R Daglas","year":"2016","unstructured":"Daglas R, Cotton SM, Allott K, Yucel M, Macneil CA, Hasty MK, et al. A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: a 12-month follow-up study. Eur Psychiatry. 2016;31:20\u20138.","journal-title":"Eur Psychiatry"},{"issue":"2","key":"688_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.euroneuro.2014.09.005","volume":"25","author":"K Muralidharan","year":"2015","unstructured":"Muralidharan K, Kozicky JM, Bucker J, Silveira LE, Torres IJ, Yatham LN. Are cognitive deficits similar in remitted early bipolar I disorder patients treated with lithium or valproate? Data from the STOP-EM study. Eur Neuropsychopharmacol. 2015;25(2):223\u201330.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"688_CR32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1399-5618.2008.00628.x","volume":"10","author":"MK Holmes","year":"2008","unstructured":"Holmes MK, Erickson K, Luckenbaugh DA, Drevets WC, Bain EE, Cannon DM, et al. A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Bipolar Disord. 2008;10(7):806\u201315.","journal-title":"Bipolar Disord"},{"issue":"Suppl 1","key":"688_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-5618.2007.00481.x","volume":"9","author":"V Senturk","year":"2007","unstructured":"Senturk V, Goker C, Bilgic A, Olmez S, Tugcu H, Oncu B, et al. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord. 2007;9(Suppl 1):136\u201344.","journal-title":"Bipolar Disord"},{"key":"688_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.comppsych.2016.07.008","volume":"71","author":"E Mora","year":"2016","unstructured":"Mora E, Portella MJ, Forcada I, Vieta E, Mur M. A preliminary longitudinal study on the cognitive and functional outcome of bipolar excellent lithium responders. Compr Psychiatry. 2016;71:25\u201332.","journal-title":"Compr Psychiatry"},{"issue":"5","key":"688_CR35","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4088\/JCP.v69n0504","volume":"69","author":"M Mur","year":"2008","unstructured":"Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J Clin Psychiatry. 2008;69(5):712\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"688_CR36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1600-0447.2008.01245.x","volume":"118","author":"M Mur","year":"2008","unstructured":"Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. Acta Psychiatr Scand. 2008;118(5):373\u201381.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"688_CR37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00004714-198812000-00008","volume":"8","author":"RT Joffe","year":"1988","unstructured":"Joffe RT, MacDonald C, Kutcher SP. Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. J Clin Psychopharmacol. 1988;8(6):425\u20138.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"688_CR38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4088\/JCP.08m04673yel","volume":"71","author":"C Lopez-Jaramillo","year":"2010","unstructured":"Lopez-Jaramillo C, Lopera-Vasquez J, Ospina-Duque J, Garcia J, Gallo A, Cortez V, et al. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry. 2010;71(8):1055\u201360.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"688_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hup.2510","volume":"31","author":"G Bersani","year":"2016","unstructured":"Bersani G, Quartini A, Zullo D, Iannitelli A. Potential neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment: preliminary results. Hum Psychopharmacol. 2016;31(1):19\u201328.","journal-title":"Hum Psychopharmacol"},{"key":"688_CR40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jad.2015.10.008","volume":"190","author":"A Sabater","year":"2016","unstructured":"Sabater A, Garcia-Blanco AC, Verdet HM, Sierra P, Ribes J, Villar I, et al. Comparative neurocognitive effects of lithium and anticonvulsants in long-term stable bipolar patients. J Affect Disord. 2016;190:34\u201340.","journal-title":"J Affect Disord"},{"issue":"6","key":"688_CR41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/JCP.0b013e31829c96e9","volume":"33","author":"Y Lin","year":"2013","unstructured":"Lin Y, Lin Y, Li X, Lao G, Jiang Z, Ye B, et al. Monotherapy with lithium or valproate or respectively combination therapy with quetiapine have similar effect on cognitive functions in Chinese euthymic patients with bipolar disorder: a cross-sectional survey. J Clin Psychopharmacol. 2013;33(6):817\u20139.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"688_CR42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/wps.20462","volume":"16","author":"M Alda","year":"2017","unstructured":"Alda M. Who are excellent lithium responders and why do they matter? World Psychiatry. 2017;16(3):319\u201320.","journal-title":"World Psychiatry"},{"issue":"5","key":"688_CR43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S1461145710000404","volume":"13","author":"JK Rybakowski","year":"2010","unstructured":"Rybakowski JK, Suwalska A. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol. 2010;13(5):617\u201322.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"11","key":"688_CR44","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/archpsyc.65.11.1331","volume":"65","author":"LV Kessing","year":"2008","unstructured":"Kessing LV, Sondergard L, Forman JL, Andersen PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry. 2008;65(11):1331\u20135.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"688_CR45","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0006-3223(00)00979-3","volume":"48","author":"HK Manji","year":"2000","unstructured":"Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry. 2000;48(8):740\u201354.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"688_CR46","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2353\/ajpath.2007.061178","volume":"170","author":"A Caccamo","year":"2007","unstructured":"Caccamo A, Oddo S, Tran LX, LaFerla FM. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol. 2007;170(5):1669\u201375.","journal-title":"Am J Pathol"},{"issue":"2","key":"688_CR47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S1461145707007821","volume":"11","author":"KN Fountoulakis","year":"2008","unstructured":"Fountoulakis KN, Vieta E, Bouras C, Notaridis G, Giannakopoulos P, Kaprinis G, et al. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int J Neuropsychopharmacol. 2008;11(2):269\u201387.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"688_CR48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2010.00792.x","volume":"12","author":"MN Pavuluri","year":"2010","unstructured":"Pavuluri MN, Passarotti AM, Mohammed T, Carbray JA, Sweeney JA. Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder. Bipolar Disord. 2010;12(2):213\u201320.","journal-title":"Bipolar Disord"},{"issue":"4","key":"688_CR49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/JCP.0b013e3180a76dd2","volume":"27","author":"NS Kaye","year":"2007","unstructured":"Kaye NS, Graham J, Roberts J, Thompson T, Nanry K. Effect of open-label lamotrigine as monotherapy and adjunctive therapy on the self-assessed cognitive function scores of patients with bipolar I disorder. J Clin Psychopharmacol. 2007;27(4):387\u201391.","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"688_CR50","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4088\/JCP.v65n1107","volume":"65","author":"A Khan","year":"2004","unstructured":"Khan A, Ginsberg LD, Asnis GM, Goodwin FK, Davis KH, Krishnan AA, et al. Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder. J Clin Psychiatry. 2004;65(11):1483\u201390.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"688_CR51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.jcp.0000204332.64390.f3","volume":"26","author":"C Daban","year":"2006","unstructured":"Daban C, Martinez-Aran A, Torrent C, Sanchez-Moreno J, Goikolea JM, Benabarre A, et al. Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results. J Clin Psychopharmacol. 2006;26(2):178\u201381.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"688_CR52","first-page":"46","volume":"8","author":"CT Gualtieri","year":"2006","unstructured":"Gualtieri CT, Johnson LG. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed. 2006;8(3):46.","journal-title":"MedGenMed"},{"issue":"12","key":"688_CR53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","volume":"271","author":"CL Bowden","year":"1994","unstructured":"Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994;271(12):918\u201324.","journal-title":"JAMA"},{"issue":"1","key":"688_CR54","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","volume":"149","author":"TW Freeman","year":"1992","unstructured":"Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 1992;149(1):108\u201311.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"688_CR55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97\u2013170.","journal-title":"Bipolar Disord"},{"issue":"4","key":"688_CR56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.yebeh.2006.03.007","volume":"8","author":"M Aikia","year":"2006","unstructured":"Aikia M, Jutila L, Salmenpera T, Mervaala E, Kalviainen R. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy. Epilepsy Behav. 2006;8(4):750\u20135.","journal-title":"Epilepsy Behav"},{"key":"688_CR57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2147\/NDT.S5903","volume":"5","author":"GA Shehata","year":"2009","unstructured":"Shehata GA, Bateh Ael A, Hamed SA, Rageh TA, Elsorogy YB. Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy. Neuropsychiatr Dis Treat. 2009;5:527\u201333.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"688_CR58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yebeh.2008.11.012","volume":"14","author":"KA Wesnes","year":"2009","unstructured":"Wesnes KA, Edgar C, Dean AD, Wroe SJ. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav. 2009;14(3):522\u20138.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"688_CR59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1528-1157.1987.tb03679.x","volume":"28","author":"AP Aldenkamp","year":"1987","unstructured":"Aldenkamp AP, Alpherts WC, Moerland MC, Ottevanger N, Van Parys JA. Controlled release carbamazepine: cognitive side effects in patients with epilepsy. Epilepsia. 1987;28(5):507\u201314.","journal-title":"Epilepsia"},{"issue":"3","key":"688_CR60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acps.12133","volume":"128","author":"C Bourne","year":"2013","unstructured":"Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013;128(3):149\u201362.","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"688_CR61","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biopsych.2007.02.001","volume":"62","author":"DC Glahn","year":"2007","unstructured":"Glahn DC, Bearden CE, Barguil M, Barrett J, Reichenberg A, Bowden CL, et al. The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry. 2007;62(8):910\u20136.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"688_CR62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-5618.2006.00296.x","volume":"8","author":"DC Glahn","year":"2006","unstructured":"Glahn DC, Bearden CE, Cakir S, Barrett JA, Najt P, Serap Monkul E, et al. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord. 2006;8(2):117\u201323.","journal-title":"Bipolar Disord"},{"issue":"1\u20133","key":"688_CR63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(02)00075-7","volume":"76","author":"AC Altamura","year":"2003","unstructured":"Altamura AC, Salvadori D, Madaro D, Santini A, Mundo E. Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. J Affect Disord. 2003;76(1\u20133):267\u201371.","journal-title":"J Affect Disord"},{"issue":"3","key":"688_CR64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","volume":"6","author":"G Sachs","year":"2004","unstructured":"Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2004;6(3):213\u201323.","journal-title":"Bipolar Disord"},{"issue":"2","key":"688_CR65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/15622975.2012.665177","volume":"15","author":"AH Young","year":"2014","unstructured":"Young AH, McElroy SL, Olausson B, Paulsson B. A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder. World J Biol Psychiatry. 2014;15(2):96\u2013112.","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"688_CR66","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4088\/JCP.v68n0804","volume":"68","author":"PD Harvey","year":"2007","unstructured":"Harvey PD, Hassman H, Mao L, Gharabawi GM, Mahmoud RA, Engelhart LM. Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study. J Clin Psychiatry. 2007;68(8):1186\u201394.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"688_CR67","first-page":"13","volume":"28","author":"F Franza","year":"2016","unstructured":"Franza F. Risk and efficacy in cognitive functions in Bipolar Disorder II with atypical antipsychotic augmentation. Psychiatr Danub. 2016;28(Suppl 1):13\u20137.","journal-title":"Psychiatr Danub"},{"issue":"6","key":"688_CR68","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.comppsych.2010.12.009","volume":"52","author":"C Torrent","year":"2011","unstructured":"Torrent C, Martinez-Aran A, Daban C, Amann B, Balanza-Martinez V, del Mar Bonnin C, et al. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr Psychiatry. 2011;52(6):613\u201322.","journal-title":"Compr Psychiatry"},{"key":"688_CR69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-9-4","volume":"9","author":"A Duffy","year":"2009","unstructured":"Duffy A, Milin R, Grof P. Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine. BMC Psychiatry. 2009;9:4.","journal-title":"BMC Psychiatry"},{"key":"688_CR70","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","volume":"184","author":"M Tohen","year":"2004","unstructured":"Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser vs. mood stabiliser alone. Br J Psychiatry. 2004;184:337\u201345.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"688_CR71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"M Tohen","year":"2002","unstructured":"Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59(1):62\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"688_CR72","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","volume":"162","author":"M Tohen","year":"2005","unstructured":"Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry. 2005;162(7):1281\u201390.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"688_CR73","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","volume":"57","author":"M Tohen","year":"2000","unstructured":"Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry. 2000;57(9):841\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"688_CR74","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","volume":"156","author":"M Tohen","year":"1999","unstructured":"Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, et al. Olanzapine versus placebo in the treatment of acute mania Olanzapine HGEH Study Group. Am J Psychiatry. 1999;156(5):702\u20139.","journal-title":"Am J Psychiatry"},{"key":"688_CR75","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0924-977X(02)80454-0","volume":"12","author":"D Yurgelun-Todd","year":"2002","unstructured":"Yurgelun-Todd D, Shi L, Zhu B, Namjoshi M, Tunis S, Baker R, et al. Olanzapine vs divalproex: prospective comparison on self-reported cognitive function in patients with bipolar disorder. Eur Neuropsychopharmacol. 2002;12:308\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"688_CR76","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1185\/030079904125004493","volume":"20","author":"L Shi","year":"2004","unstructured":"Shi L, Schuh LM, Trzepacz PT, Huang LX, Namjoshi MA, Tohen M. Improvement of positive and negative syndrome scale cognitive score associated with olanzapine treatment of acute mania. Curr Med Res Opin. 2004;20(9):1371\u20136.","journal-title":"Curr Med Res Opin"},{"issue":"9799","key":"688_CR77","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","volume":"378","author":"A Cipriani","year":"2011","unstructured":"Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378(9799):1306\u201315.","journal-title":"Lancet"},{"issue":"7","key":"688_CR78","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"GS Sachs","year":"2002","unstructured":"Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002;159(7):1146\u201354.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"688_CR79","first-page":"176","volume":"21","author":"J Segal","year":"1998","unstructured":"Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol. 1998;21(3):176\u201380.","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"688_CR80","first-page":"231","volume":"28","author":"M Reinares","year":"2000","unstructured":"Reinares M, Martinez-Aran A, Colom F, Benabarre A, Salamero M, Vieta E. Long-term effects of the treatment with risperidone versus conventional neuroleptics on the neuropsychological performance of euthymic bipolar patients [in Spanish]. Actas espanolas de psiquiatria. 2000;28(4):231\u20138.","journal-title":"Actas espanolas de psiquiatria"},{"issue":"4","key":"688_CR81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-002-1272-2","volume":"165","author":"H Allain","year":"2003","unstructured":"Allain H, Tessier C, Bentue-Ferrer D, Tarral A, Le Breton S, Gandon M, et al. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology. 2003;165(4):419\u201329.","journal-title":"Psychopharmacology"},{"issue":"2","key":"688_CR82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/YIC.0b013e32834e3bea","volume":"27","author":"JM Kozicky","year":"2012","unstructured":"Kozicky JM, Torres IJ, Bond DJ, Lam RW, Yatham LN. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder. Int Clin Psychopharmacol. 2012;27(2):91\u20139.","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"688_CR83","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2215-0366(17)30046-9","volume":"4","author":"LN Yatham","year":"2017","unstructured":"Yatham LN, Mackala S, Basivireddy J, Ahn S, Walji N, Hu C, et al. Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study. Lancet Psychiatry. 2017;4(3):208\u201317.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"688_CR84","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/08039488.2011.643484","volume":"66","author":"LJ Wang","year":"2012","unstructured":"Wang LJ, Yeh CB, Huang YS, Tang CS, Chou WJ, Chou MC, et al. Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder. Nordic J Psychiatry. 2012;66(4):276\u201382.","journal-title":"Nordic J Psychiatry"},{"issue":"6","key":"688_CR85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/15622975.2016.1245441","volume":"18","author":"NE Steen","year":"2017","unstructured":"Steen NE, Aas M, Simonsen C, Dieset I, Tesli M, Nerhus M, et al. Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders. World J Biol Psychiatry. 2017;18(6):471\u201382.","journal-title":"World J Biol Psychiatry"},{"issue":"11","key":"688_CR86","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","volume":"170","author":"I Pacchiarotti","year":"2013","unstructured":"Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170(11):1249\u201362.","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"688_CR87","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.schres.2015.10.021","volume":"169","author":"NE Steen","year":"2015","unstructured":"Steen NE, Aas M, Simonsen C, Dieset I, Tesli M, Nerhus M, et al. Serum level of venlafaxine is associated with better memory in psychotic disorders. Schizophr Res. 2015;169(1\u20133):386\u201392.","journal-title":"Schizophr Res"},{"issue":"10","key":"688_CR88","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0269881118798614","volume":"32","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zheng W, Liu W, Wang C, Zhan Y, Li H, et al. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. J Psychopharmacol. 2018;32(10):1118\u201326.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"688_CR89","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0253-7176.53311","volume":"31","author":"Jaykaran","year":"2009","unstructured":"Jaykaran, Bhardwaj P, Kantharia ND, Yadav P, Panwar A. Effect of fluoxetine on some cognitive functions of patients of depression. Indian J Psychol Med. 2009;31(1):24\u20139.","journal-title":"Indian J Psychol Med"},{"issue":"4","key":"688_CR90","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0361-9230(01)00780-8","volume":"58","author":"Y Levkovitz","year":"2002","unstructured":"Levkovitz Y, Caftori R, Avital A, Richter-Levin G. The SSRIs drug fluoxetine, but not the noradrenergic tricyclic drug desipramine, improves memory performance during acute major depression. Brain Res Bull. 2002;58(4):345\u201350.","journal-title":"Brain Res Bull"},{"issue":"1","key":"688_CR91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0b013e31802e0002","volume":"27","author":"A Mowla","year":"2007","unstructured":"Mowla A, Mosavinasab M, Pani A. Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. J Clin Psychopharmacol. 2007;27(1):67\u201370.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"688_CR92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/1099-078X(200007\/09)15:3<217::AID-BIN57>3.0.CO;2-C","volume":"15","author":"T Hall","year":"2000","unstructured":"Hall T, Barrera RD, Randon M. Reversible memory loss following treatment with fluoxetine: a case study. Behav Interv. 2000;15(3):217\u201324.","journal-title":"Behav Interv"},{"issue":"5","key":"688_CR93","doi-asserted-by":"crossref","first-page":"e007504","DOI":"10.1136\/bmjopen-2014-007504","volume":"5","author":"R Patel","year":"2015","unstructured":"Patel R, Lloyd T, Jackson R, Ball M, Shetty H, Broadbent M, et al. Mood instability is a common feature of mental health disorders and is associated with poor clinical outcomes. BMJ Open. 2015;5(5):e007504.","journal-title":"BMJ Open"},{"issue":"4","key":"688_CR94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1192\/bjp.bp.114.158543","volume":"207","author":"MR Broome","year":"2015","unstructured":"Broome MR, Saunders KE, Harrison PJ, Marwaha S. Mood instability: significance, definition and measurement. Br J Psychiatry. 2015;207(4):283\u20135.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"688_CR95","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-5618.2010.00830.x","volume":"12","author":"LN Yatham","year":"2010","unstructured":"Yatham LN, Torres IJ, Malhi GS, Frangou S, Glahn DC, Bearden CE, et al. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord. 2010;12(4):351\u201363.","journal-title":"Bipolar Disord"},{"key":"688_CR96","volume-title":"MCCB: matrics consensus cognitive battery","author":"KH Nuechterlein","year":"2006","unstructured":"Nuechterlein KH, Green MF. MCCB: matrics consensus cognitive battery. Los Angeles: MATRICS Assessment; 2006."},{"key":"688_CR97","volume-title":"Stroop color and word test.: a manual for clinical and experimental uses","author":"CJ Golden","year":"1978","unstructured":"Golden CJ, Freshwater SM. Stroop color and word test: a manual for clinical and experimental uses. Chicago: Stoelting; 1978"},{"key":"688_CR98","unstructured":"Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Reitan Neuropsychology; 1985."},{"key":"688_CR99","unstructured":"Heaton R. Wisconsin card sorting test manual; revised and expanded. Psychological Assessment Resources; 1981. p. 5\u201357."},{"issue":"1","key":"688_CR100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/0022-006X.56.1.123","volume":"56","author":"DC Delis","year":"1988","unstructured":"Delis DC, Freeland J, Kramer JH, Kaplan E. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol. 1988;56(1):123.","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"688_CR101","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/arclin\/acx021","volume":"32","author":"TM Roebuck-Spencer","year":"2017","unstructured":"Roebuck-Spencer TM, Glen T, Puente AE, Denney RL, Ruff RM, Hostetter G, et al. Cognitive screening tests versus comprehensive neuropsychological test batteries: a National Academy of Neuropsychology Education Paperdagger. Arch Clin Neuropsychol. 2017;32(4):491\u20138.","journal-title":"Arch Clin Neuropsychol"},{"issue":"3","key":"688_CR102","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bdi.12595","volume":"20","author":"KW Miskowiak","year":"2018","unstructured":"Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, et al. Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians. Bipolar Disord. 2018;20(3):184\u201394.","journal-title":"Bipolar Disord"},{"key":"688_CR103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-244X-13-127","volume":"13","author":"J Gomez-Benito","year":"2013","unstructured":"Gomez-Benito J, Guilera G, Pino O, Rojo E, Tabares-Seisdedos R, Safont G, et al. The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients. BMC Psychiatry. 2013;13:127.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"688_CR104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jad.2013.02.022","volume":"150","author":"AR Rosa","year":"2013","unstructured":"Rosa AR, Mercade C, Sanchez-Moreno J, Sole B, Mar Bonnin CD, Torrent C, et al. Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA). J Affect Disord. 2013;150(1):29\u201336.","journal-title":"J Affect Disord"},{"key":"688_CR105","doi-asserted-by":"crossref","unstructured":"Hafiz P, Miskowiak KW, Kessing LV, Bardram JE, editors. Design and implementation of a web-based application to assess cognitive impairment in affective disorder. In: Proceedings of the 2018 international conference on digital health, ACM; 2018.","DOI":"10.1145\/3194658.3194691"},{"issue":"8","key":"688_CR106","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bdi.12534","volume":"19","author":"KW Miskowiak","year":"2017","unstructured":"Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, et al. Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disord. 2017;19(8):614\u201326.","journal-title":"Bipolar Disord"},{"issue":"3","key":"688_CR107","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0269881116668594","volume":"31","author":"AC Bilderbeck","year":"2017","unstructured":"Bilderbeck AC, Atkinson LZ, Geddes JR, Goodwin GM, Harmer CJ. The effects of medication and current mood upon facial emotion recognition: findings from a large bipolar disorder cohort study. J Psychopharmacol. 2017;31(3):320\u20136.","journal-title":"J Psychopharmacol"},{"key":"688_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-014-0016-7","volume":"2","author":"A Pfennig","year":"2014","unstructured":"Pfennig A, Alda M, Young T, MacQueen G, Rybakowski J, Suwalska A, et al. Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplay. Int J Bipolar Disord. 2014;2:1.","journal-title":"Int J Bipolar Disord"},{"key":"688_CR109","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jad.2019.02.056","volume":"249","author":"ES Brown","year":"2019","unstructured":"Brown ES, Khaleghi N, Van Enkevort E, Ivleva E, Nakamura A, Holmes T, et al. A pilot study of brexpiprazole for bipolar depression. J Affect Disord. 2019;249:315\u20138.","journal-title":"J Affect Disord"},{"issue":"3","key":"688_CR110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/JCP.0000000000000078","volume":"34","author":"JJ Rakofsky","year":"2014","unstructured":"Rakofsky JJ, Dunlop BW, Beyer JL, Oliver AM, Mansson EE, Sancheti MT, et al. Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder. J Clin Psychopharmacol. 2014;34(3):383\u20135.","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"688_CR111","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00406-016-0743-0","volume":"267","author":"K Tournikioti","year":"2017","unstructured":"Tournikioti K, Ferentinos P, Michopoulos I, Alevizaki M, Soldatos CR, Dikeos D, et al. Clinical and treatment-related predictors of cognition in bipolar disorder: focus on visual paired associative learning. Eur Arch Psychiatry Clin Neurosci. 2017;267(7):661\u20139.","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-019-00688-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T20:01:46Z","timestamp":1665172906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-019-00688-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s40263-019-00688-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,5]]},"assertion":[{"value":"5 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"KEAS is supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health and Social Care. NX is a Rhodes Scholar.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Ni Xu, Benjamin Huggon and Kate E.A. Saunders have no conflicts of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}